metrizamide has been researched along with Arterial-Occlusive-Diseases* in 2 studies
1 trial(s) available for metrizamide and Arterial-Occlusive-Diseases
| Article | Year |
|---|---|
Two new contrast media in peripheral arteriography: a double blind study in patients with arterial insufficiency in the legs.
Two new contrast media, Amipaque (metrizamide, Nyegaard & Co A/S, Oslo) and Hexabrix (ioxaglic acid, Laboratoire Guerbet, Paris) were compared in a double blind study in patients with arterial insufficiency in the legs. The incidence of subjective adverse effects (pain and sensation of heat) was low and similar with both contrast agents. Also the effects on heart rate and blood pressure were small and transient and similar with both contrast agents. Topics: Adult; Aged; Angiography; Arterial Occlusive Diseases; Blood Pressure; Clinical Trials as Topic; Contrast Media; Female; Heart Rate; Humans; Leg; Male; Metrizamide; Middle Aged; Pain | 1980 |
1 other study(ies) available for metrizamide and Arterial-Occlusive-Diseases
| Article | Year |
|---|---|
Peripheral angiography with metrizamide.
Metrizamide, tested in 41 patients, caused less discomfort than injection of Isopaque Cerebral, when injected into the abdominal artery. In view of the high price of metrizamide, it is indicated for what angiographic studies the Malmö General Hospital employs this contrast medium. Topics: Adult; Aged; Angiography; Arterial Occlusive Diseases; Female; Humans; Leg; Male; Meglumine; Metrizamide; Metrizoic Acid; Middle Aged; Osmolar Concentration; Pain | 1979 |